|
J Biol Chem, Vol. 273, Issue 17, 10402-10410, April 24, 1998
Characterization of a Ca2+ Release-activated
Nonselective Cation Current Regulating Membrane Potential and
[Ca2+]i Oscillations in Transgenically
Derived -Cells*
Michael W.
Roe ,
Jennings F.
Worley III§,
Feng
Qian¶,
Natalia
Tamarina ,
Anshu A.
Mittal ,
Flora
Dralyuk ,
Nathaniel T.
Blair ,
Robert J.
Mertz§,
Louis H.
Philipson , and
Iain D.
Dukes§
From the Departments of Medicine and
¶ Pharmacology and Physiology, University of Chicago, Chicago,
Illinois 60637 and the § Department of Cell Physiology,
Glaxo Wellcome Research Institute,
Research Triangle Park, North Carolina 27709
 |
ABSTRACT |
Although stimulation of insulin secretion by
glucose is regulated by coupled oscillations of membrane potential and
intracellular Ca2+ ([Ca2+]i),
the membrane events regulating these oscillations are incompletely
understood. In the presence of glucose and tetraethylammonium, transgenically derived -cells ( TC3-neo) exhibit coupled voltage and [Ca2+]i oscillations strikingly similar to
those observed in normal islets in response to glucose. Using these
cells as a model system, we investigated the membrane conductance
underlying these oscillations. Alterations in delayed
rectifier or Ca2+-activated K+ channels
were excluded as a source of the conductance oscillations, as they
are completely blocked by tetraethylammonium. ATP-sensitive K+ channels were also excluded, since the ATP-sensitive
K+ channel blocker tolbutamide substituted for glucose in
inducing [Ca2+]i oscillations. Thapsigargin,
which depletes intracellular Ca2+ stores, and maitotoxin,
an activator of nonselective cation channels, both converted the
glucose-dependent [Ca2+]i
oscillations into a sustained elevation. On the other hand, both SKF
96365, a blocker of Ca2+ store-operated channels, and
external Na+ removal suppressed the glucose-stimulated
[Ca2+]i oscillations. Maitotoxin activated a
nonselective cation current in TC3 cells that was attenuated by
removal of extracellular Na+ and by SKF 96365, in the same
manner to a current activated in mouse -cells following depletion of
intracellular Ca2+ stores. Currents similar to these are
produced by the mammalian trp-related channels, a gene
family that includes Ca2+ store-operated channels and
inositol 1,4,5-trisphosphate-activated channels. We found several of
the trp family genes were expressed in TC3 cells by
reverse transcriptase polymerase chain reaction using specific primers,
but by Northern blot analysis, mtrp-4 was the predominant
message expressed. We conclude that a conductance underlying
glucose-stimulated oscillations in -cells is provided by a
Ca2+ store depletion-activated nonselective cation current,
which is plausibly encoded by homologs of trp genes.
 |
INTRODUCTION |
Pancreatic islet -cell secretion of insulin stimulated by
glucose is dependent upon elevations in intracellular calcium
concentration ([Ca2+]i)1
(1). Together, two voltage-dependent processes have been
proposed to constitute the glucose-stimulated rise in
[Ca2+]i: the influx of extracellular
Ca2+ through Ca2+ channels (2-4) and the
release of intracellular Ca2+ from the endoplasmic
reticulum (ER) (5-7). Glucose initiates changes in membrane potential
via an increase in cytosolic ATP, derived from the glycolytic reduction
of NAD+, that results in block of ATP-sensitive
K+ channels (KATP) (8, 9). Consequently, the membrane
potential slowly depolarizes from approximately 65 mV, whereupon
trains of action potentials occur (the active phase), interrupted by quiescent periods of hyperpolarization (the silent phase), both forming
the so-called electrical bursting behavior characteristic of
glucose-stimulated islets (10-12). Closely coupled with this bursting
activity are oscillations in [Ca2+]i that
ultimately determine the oscillatory nature of insulin secretion (5,
11-14). The mechanism underlying these oscillations in membrane
potential, [Ca2+]i, and insulin secretion remains
uncertain, but most likely stems from a cyclical activation of an ion
conductance governed indirectly by metabolism, changes in
[Ca2+]i, or some hitherto uncharacterized
intracellular mediator (15, 16).
Confounding an early resolution of this puzzle is the profusion of
membrane currents present in -cells. Thus, in addition to
ATP-sensitive K+ current (IKATP) and
voltage-dependent Ca2+
(ICa) and Na+ currents, delayed
rectifier K+ (IKDR),
Ca2+-activated K+
(IKCa), and G-protein-coupled inward rectifier
K+ currents have been described, all of which could
contribute to the regulation of the -cell membrane potential by
glucose (17-20). More recently, a nonselective cation current whose
conductance is regulated by the Ca2+ content of the ER
(ICRAN; Ca2+ release-activated
nonselective cation current) was found in mouse -cells (21). This
current could be activated indirectly by ER Ca2+ store
depletion or directly by maitotoxin (MTX) (12, 21). Carried primarily
by Na+, ICRAN produces membrane
depolarization and indirectly, an elevation in
[Ca2+]i, as a consequence of activation of
voltage-dependent ICa (21).
Although membrane potential and [Ca2+]i
oscillations have been readily recorded from whole mouse islets and
-cell clusters (11-14, 20), single mouse -cells normally do not
respond to glucose stimulation with regular oscillatory activity (16). We have previously reported that a stable transgenically derived murine
insulinoma cell line ( TC3-neo) also responds to glucose with large
amplitude oscillations in [Ca2+]i when in the
presence of 10-20 mM tetraethylammonium (TEA), a blocker
of delayed rectifier K+ channels (Kv) (20). We have thus
utilized this cell line to characterize and identify the membrane
conductance that underlies glucose-stimulated oscillatory activity.
In this article, we provide evidence that activation of
ICRAN in TC3-neo cells regulates
glucose-stimulated [Ca2+]i oscillations and
insulin secretion. Furthermore, to characterize the molecular identity
of ICRAN, we detected in insulin-secreting insulinoma cells and mouse islets the expression of multiple
trp (transient receptor potential) genes that are known to
encode intracellular Ca2+ store release-activated channels
in other mammalian and insect tissues (22-28). Our findings suggest
that the interaction between intracellular Ca2+ stores and
plasma membrane conductances is an important mechanism that controls
glucose-dependent stimulus response coupling in -cells.
 |
MATERIALS AND METHODS |
TC3 cells were cultured as described elsewhere (20, 29). A
clonal subline ( TC3-neo) was isolated after transfection with
pSV2-neo by electroporation (20) and maintained in the continued
presence of 1 mg/ml G418 (Life Technologies, Inc.). Cells were seeded
for 4-6 days in Dulbecco's modified Eagle's medium supplemented with
15% normal horse serum, 2.5% fetal calf serum, 50 units/ml
penicillin, 50 µg/ml streptomycin. Eighteen hours prior to
experiments, medium was changed to RPMI 1640 medium containing 15%
dialyzed horse serum, 2.5% dialyzed fetal calf serum, 1 mM
glucose, and antibiotics as above. MIN6 cells were cultured essentially
as described (30). Islets of Langerhans were isolated from
8-10-week-old C57BL/KsJ (+/+) mice (Jackson Laboratories) as described
(5, 9, 12).
Measurement of [Ca2+]i--
TC3-neo
cells were loaded with Fura-2 by a 25-min incubation at 37 °C in
Krebs-Ringer buffer containing (in mM): 119 NaCl, 4.7 KCl,
1.8 CaCl2, 1.2 MgSO4, 1.2 KH2PO4, 25 NaHCO3, 0 glucose, supplemented with 5 µM acetoxymethyl ester of Fura-2
(Molecular Probes Inc.). In some experiments, external NaCl was
replaced with equimolar amounts of
N-methyl-D-glucamine-Cl.
[Ca2+]i was expressed as the ratio change in
fluorescence (340/380) as detailed in full elsewhere (9, 20).
Patch Clamp Current Recordings--
Single TC3-neo cells were
voltage-clamped using perforated patch clamp techniques. Patch
electrodes contained 80 mM potassium aspartate, 50 mM KCl, 5 mM NaCl, 5 mM
MgCl2, 10 mM HEPES/KOH (pH 7.2), and 100-120
µg/ml nystatin (9, 20). The perfusion medium was a Krebs-Ringer
buffer solution as detailed above.
Insulin Secretion Measurements--
TC3-neo cells were plated
at a density of 25 × 104/cm2 and cultured
overnight in RPMI 1640 medium as described above. Insulin secretion
measurements were made in the presence of 0 or 1 mM glucose
in the presence or absence of TEA, maitotoxin, or thapsigargin, as
described previously (20). The concentration of insulin was determined
using an SPA assay kit (Amersham Pharmacia Biotech) and calibrated
using rat insulin (Novo) as standard.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
Identification and Amplification of Probes for trp-related Gene
Expression--
Mouse brain, TC3-neo, and MIN6 poly(A)+
RNA were prepared using an oligo(dT) binding method (Quickprep micro
mRNA kit, Amersham Pharmacia Biotech) and first strand cDNA was
reverse-transcribed using random primers (Superscript II transcriptase,
Life Technologies, Inc.). Transcripts of the six known members of the
murine trp (mtrp) family (accession number in
parentheses) were amplified by polymerase chain reaction (PCR)
using the following oligonucleotide primers: mtrp-1 (GenBank>U40980)
5'-GATTTTGGGAAATTTCTGGGAATG-3' (sense) and
5'-TTTATCCTCATGACTTGCTATCA-3' (antisense); mtrp-2 (U40981)
5'-GACATGATCCGGTTCATGTTC-3' (sense) and 5'-CATCAGCATCATCCTCGATCT-3' (antisense); mtrp-3 (U40982) 5'-GACATATTCAAGTTCATGCGTTCTC-3' (sense) and 5'-ACATCACTGTCATCCTCGATCTC-3' (antisense);
mtrp-4 (X90697) 5'-CTGCAGATATCTCTGGGAAGG-3' (sense) and
5'-GCTTTGTTCGAGCAAATTTCC-3' (antisense); mtrp-5 (U40984)
5'-TCTACTGCCTAGTACTACTGGC-3' (sense) and 5'-GTAGGAGTTATTCATCATGGCG-3'
(antisense); mtrp-6 (U40969) 5'-GATATCTTCAAATTCATGGTCATA-3'
(sense) and 5'-GTCCGCATCATCCTCAATTTC-3' (antisense). The PCR
protocol used consisted of an initial denaturation at 94 °C for 3 min; followed by five cycles of 94 °C for 1 min, 64 °C for
30 s; followed directly by 25 cycles of 94 °C for 1 min,
60 °C for 1 min, and 72 °C for 30 s.
Products were run on 1.5% agarose gels, visualized by staining with
ethidium bromide, and transferred to Hybond-N+ (Amersham
Pharmacia Biotech) for subsequent analysis by Southern blot.
Oligonucleotides corresponding to sequences within the amplified mtrp-1-3, -5, and -6 cDNAs were
end-labeled with 32P and hybridized overnight at 42 °C
in 5× SSC, 5× Denhardt's, 0.5% SDS, 125 µg/ml salmon sperm
DNA: trp-1 5'-TGTGTGGGCATCTTCTGCGAACAGC-3'; trp-2
5'-AGGAA-TCCGAGAAGCTAGGCAATT-3'; trp3
5'-GGCCAAAGTAAATCCTGCTTTTA-3'; trp-5
5'-GACCAGAGCTATTGATGAACCTAAC-3'; trp-6
5'-AGTCAGTGGTCATTAA-CTACA-3'. After hybridization, blots were
washed in 2× SSC at room temperature for 30 min and at 50 °C in 1×
SSC. After washing, blots were exposed to X-Omat film for 5 to 20 min
at room temperature. The mtrp-4 fragment was probed with the
400-base pair cDNA itself, after labeling with 32P
using a random primer kit (Stratagene, La Jolla, CA). The blot was
hybridized overnight at 42 °C in 50% formamide, 5× SSC, 5× Denhardt's solution, 0.5% SDS, 125 µg/ml salmon sperm DNA. After hybridization, the blot was washed in 2× SSC, 0.1% SDS for 30 min at
room temperature, and in 0.1× SSC, 0.1% SDS at 60 °C for 30 min.
The blot was exposed to X-Omat film for 1 h at 70 °C. Sequenced probes were then subcloned for use in Northern blot analysis.
Northern Blot Analysis--
For RNA isolation, TC3 cells were
grown to near confluence, washed three times with phosphate-buffered
saline, and lysed in solution containing 4 M guanidine
thiocyanate, 100 mM Tris-HCl (pH 7.5), 1%
-mercaptoethanol, and 0.5% lauryl sarcosinate. Total RNA was
purified by centrifugation through a 0.9-ml cushion of 5.7 M CsCl in a TLS-55 rotor at 53000 rpm for 4 h in the
Optima TL ultracentrifuge (Beckman, Palo Alto, CA). Mouse brain RNA was isolated using TRIzol (Life Technologies, Inc.) according to the manufacturer's protocol and purified by centrifugation through CsCl as
described above. RNA was size-fractionated in the presence of ethidium
bromide (50 µg/ml) in a 1% agarose-formaldehyde gel at 100 V and
transferred to Hybond N nylon membranes (Amersham Pharmacia Biotech).
The probes used were the subcloned PCR products described in the
previous section, except in the case of mtrp-4, for which a
full-length mtrp-4 clone derived from a TC3 cDNA library was employed.2 Probes
were gel-purified and labeled with [ -32P]dCTP using
Prime-It random primer labeling kit (Stratagene, La Jolla, CA). After
overnight hybridization at 68 °C in ExpressHybe solution
(CLONTECH) blots were washed to a final stringency
of 0.1× SSC, 0.1% SDS at 60 °C and exposed to BioMax MS-1 film
with BioMax intensifying screen (Eastman Kodak Corp.) for 18 h to
1 week at 80 °C.
 |
RESULTS |
In contrast to normal mouse islets, the murine insulinoma cell
line, TC3-neo, does not usually respond to a step increase in
glucose concentration with regular oscillatory increases in [Ca2+]i. Instead, a slow rise in
[Ca2+]i occurs with occasional intermittent
spikes (Fig. 1A). Exposure of
TC3-neo cells to 20 mM TEA, a blocker of delayed rectifier K+ channels, however, permitted the generation by
glucose of large regular oscillations in [Ca2+]i
of a type normally seen in mouse islets exposed to nutrients (5, 13,
20) (Fig. 1A). In the absence of glucose, TEA was without
effect (n = 5). This glucose dependence suggests that
the governing ionic conductance is carried by
IKATP as in the case of primary -cells,
i.e. IKATP sets the resting membrane potential
(17, 18). Indeed, activation of IKATP with 250 µM diazoxide fully suppressed the TEA-activated
[Ca2+]i oscillations (Fig. 1B). The
[Ca2+]i oscillations were also immediately
abolished by exposure to either low Ca2+-containing
external solutions (50 µM EGTA, no added
Ca2+) or 1 µM nitrendipine, indicating their
dependence on depolarization-triggered Ca2+ influx through
voltage-dependent Ca2+ channels (VDCC) (Fig.
1C).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
TC3-neo cells display
voltage-dependent, TEA-activated
[Ca2+]i oscillations.
A, changes in [Ca2+]i in a single
TC3-neo cell, expressed as ratiometric changes in Fura-2
fluorescence (F340/F380),
following exposure to a maximally stimulating concentration of glucose
(1 mM; GLU, open bar). The subsequent
addition of tetraethylammonium (20 mM; TEA,
filled bar) activated large amplitude oscillations in
[Ca2+]i. B, induction of membrane
hyperpolarization with diazoxide (250 µM; DZ,
hatched bar), an activator of ATP-sensitive K+
channels abolished the oscillations in [Ca2+]i
induced by glucose and TEA. C, the
[Ca2+]i oscillations induced by glucose and TEA
were abolished by maneuvers designed to suppress Ca2+
influx. Both reduction in the extracellular Ca2+
concentration using solutions containing no added Ca2+ and
50 µM EGTA (EGTA, open bar) and
blockade of L-type Ca2+ channels using nitrendipine (1 µM; NIT, open bar) reversibly
suppressed oscillatory activity.
|
|
It has been previously suggested that glucose-induced electrical and
[Ca2+]i oscillations result from oscillations in
metabolism (15, 31, 32). However, the experiments shown in Fig.
2 (A and B) would
indicate that direct modulation of plasma membrane conductances alone
is insufficient to induce Ca2+ oscillations. In the absence
of glucose, exposure of TC3-neo cells to 100 µM
tolbutamide to block IKATP induced
[Ca2+]i oscillations only in the presence of TEA
that were indistinguishable from those generated by glucose (Fig.
2A). Furthermore, membrane depolarization induced by 20 mM KCl was able to similarly substitute for glucose in
permitting TEA to induce [Ca2+]i oscillations
(Fig. 2B). Thus, a necessity for the conductance regulating
the [Ca2+]i oscillations to be coupled to
oscillations in KATP activity or glucose metabolism seems excluded.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 2.
TEA-induced
[Ca2+]i oscillations in
TC3-neo cells can be supported by depolarizing secretagogues in
addition to glucose. Pre-exposure to 100 µM
tolbutamide (A) or 20 mM KCl (B)
induces monophasic rises in [Ca2+]i similar to
those of glucose. Addition of 20 mM TEA in both cases
activated large amplitude [Ca2+]i oscillations
(compare with Fig. 1, A-C).
|
|
We were, however, able to measure marked alterations in the
[Ca2+]i oscillations stimulated by glucose
following exposure to thapsigargin, a selective inhibitor of the ER
Ca2+ ATPases (33, 34). Although thapsigargin caused no
detectable alteration in [Ca2+]i in the absence
of glucose, addition of thapsigargin following exposure to glucose and
TEA converted the resulting [Ca2+]i oscillations
into a sustained rise in [Ca2+]i (Fig.
3A). Previous studies in mouse
pancreatic islets and -cells have indicated that the effect of
maneuvers to deplete intracellular Ca2+ stores, as
exemplified by the action of thapsigargin, result from the activation
of ICRAN (12, 21, 34).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Stimulation of
[Ca2+]i oscillations in
TC3-neo cells by ER Ca2+ store depletion-activated
nonselective cation channels. A, depletion of intracellular
Ca2+ stores by exposure to the ER Ca2+-ATPase
inhibitor thapsigargin (500 nM; TG, lower
bar) converts [Ca2+]i oscillatory activity
induced by glucose (1 mM; GLU, open
bar) and TEA (20 mM; middle bar) into a
sustained rise. In mouse islets, similar maneuvers cause activation of
a depolarizing nonselective cation current carried principally by
Na+ (21). B, reduction of extracellular
Na+ and its equimolar replacement by 119 mM
amount of the non-permeating cation
N-methyl-D-glucamine (NMDG,
lower bar) reversibly ablated the
[Ca2+]i oscillations induced by glucose (1 mM; open bar) and TEA (20 mM;
middle bar). C, exposure to the Ca2+
store-activated channel blocker SKF 96365 (60 µM;
SKF, hatched bar) also ablated the
[Ca2+]i oscillations triggered by glucose (1 mM; open bar) and TEA (20 mM;
hatched bar). D, the suppressive effect of SKF
96365 on oscillatory activity is not related to block of classical
Ca2+ entry pathways. The rise induced by exposure to KCl
(20 mM; KCl, open bar) was unaffected
by SKF 96365 (60 µM; SKF, filled
bar), but completely suppressed by the L-type Ca2+
channel blocker nitrendipine (1 µM; NIT,
hatched bar).
|
|
The principal permeating ion carrying the depolarizing current through
ICRAN in mouse -cells is Na+
(21). To test whether ICRAN was involved in
regulating the glucose-dependent oscillations in TC3-neo
cells, we therefore examined the effects of Na+
substitution. Reduction of external Na+ by substitution
with the non-permeant cation
N-methyl-D-glucamine largely suppressed the
[Ca2+]i oscillations induced in TC3-neo cells
by glucose and TEA (Fig. 3B). Similarly, application of SKF
96365, a putative blocker of intracellular Ca2+ store
release-activated channels (35) reversibly abolished the
glucose-stimulated oscillations in [Ca2+]i (Fig.
3C). Nonspecific suppressive effects of SKF 96365 on
[Ca2+]i were ruled out by the
observation that KCl-induced elevations in
[Ca2+]i were unimpaired (Fig. 3D).
Application of 100 pM MTX, an agent that directly activates
nonselective cation channels in HL60 cells (36) and
ICRAN in mouse -cells (21), caused an
immediate sustained rise in [Ca2+]i, further
indicating the prominent role of this channel in regulating
[Ca2+]i in TC3 cells (Fig.
4A). Similar to its effect on glucose-stimulated [Ca2+]i oscillations,
application of SKF 96365 also suppressed the MTX-dependent
elevation in [Ca2+]i in TC3-neo cells (Fig.
4B). Finally, diazoxide application was able to completely
reverse the MTX-induced [Ca2+]i rise (Fig.
4C), indicating that ICRAN was a
relatively small current that could be overridden by concomitant
activation of IKATP.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 4.
Maitotoxin causes a
depolarization-dependent increase in
[Ca2+]i in TC3-neo cells
related to opening of ER Ca2+ store depletion-activated
nonselective cation channels. A, exposure to 50 pM of the dinoflagellate toxin MTX caused a sustained
elevation in [Ca2+]i in TC3-neo cells. In
mouse pancreatic -cells, a similar rise in
[Ca2+]i was attributed to activation of
nonselective cation channels, leading to a depolarization-driven
increase in Ca2+ entry through L-type Ca2+
channels (21). B, the maitotoxin-induced rise in
[Ca2+]i (50 pM; MTX,
open bar) was reversibly attenuated by the Ca2+
store-operated ion channel blocker SKF 96365 (60 µM;
SKF, filled bar). C, the
maitotoxin-induced elevation in [Ca2+]i could
also be reversibly suppressed by application of the ATP-sensitive
K+ channel activator diazoxide (250 µM;
DZ, filled bar), indicating that the rise in
[Ca2+]i was likely secondary to
depolarization-dependent activation of L-type
Ca2+ channels.
|
|
To confirm the actual presence of a nonselective cation channel in
TC3-neo cells, we carried out perforated patch recordings. Application of 1-100 pM MTX caused the activation of a
non-inactivating current with a reversal potential of 10 mV (Fig.
5A), properties identical to
ICRAN observed in mouse -cells (21);
furthermore, both SKF 96365 and external Na+ removal were
able to reversibly attenuate the MTX-activated current (Fig. 5,
A and B). These findings suggest that the
increase in [Ca2+]i induced by MTX, and the
ablation of the glucose-stimulated [Ca2+]i
oscillations by SKF 96365 or external Na+ removal, were
secondary to activation and block of a Ca2+ store-operated,
nonselective cation channel, respectively.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 5.
TC3-neo cells possess maitotoxin-sensitive
nonselective cation channels A. Perforated patch recordings of
membrane current from a single TC3-neo cell. Using a 100-ms ramp
protocol ( 100 mV to 60 mV, shown in inset below panel),
traces shown are control ( ), and following exposure to 50 pM MTX ( ), which caused an increase in membrane current
recorded over a range of potentials. The reversal potential for this
current was 12 mV, as predicted for a nonselective cation channel and
similar to a store operated nonselective cation channel reported in
mouse pancreatic -cells (21). Application of 40 µM SKF
96365 ( ) caused a marked suppression of the MTX-activated current,
which was reversed on washout of the store-operated channel blocker
( ). B, in the presence of 50 pM MTX ( ),
reduction of extracellular Na+ and its equimolar
replacement by 119 mM of the non-permeating cation
N-methyl-D-glucamine ( ) caused a substantial
diminution of the MTX-activated current, which was reversed on
re-introduction of normal Na+-containing solutions and MTX
( ).
|
|
We also measured the effects of modulation of
ICRAN on insulin secretion. As we described
previously (20), in the presence of 20 mM TEA, 1 mM glucose gave a robust stimulation of insulin secretion
(Fig. 6). We investigated the effect on
insulin secretion of two mechanisms that would lead to the activation
of ICRAN. Activation of the store-operated
channel by inhibition of the ER Ca2+ ATPase with
thapsigargin greatly potentiated glucose-stimulated insulin secretion
in the presence of TEA (Fig. 6). Likewise, direct activation of
ICRAN with 50 pM MTX also markedly
increased glucose-stimulated insulin secretion (Fig. 6). Thus, indirect
or direct activation of ICRAN leads to an
amplification of glucose-stimulated insulin secretion, presumably by
enhancing depolarization-driven influx of Ca2+ (21).

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 6.
Activation of nonselective cation channels
modulates glucose-stimulated insulin secretion. Whereas
stimulatory concentrations of glucose caused only a minor stimulation
of insulin secretion (1 mM glucose, filled bar)
compared with basal insulin secretion output (0 mM glucose,
open bar), TEA (20 mM) potentiated
glucose-stimulated insulin secretion 10-fold. Addition of thapsigargin
(1 µM; TG) further augmented the insulin
secretion. Exposure to MTX (50 pM)in the presence of 1 mM glucose induced a similar amount of insulin secretion as
that produced by the combined addition of TEA and thapsigargin.
|
|
To characterize the molecular identity of ICRAN,
we used RT-PCR and Southern blots of TC3-neo and MIN6 insulinoma
cells and mouse islets to identify transcript expression and prepare
probes for Northern blot analysis. Primers (see "Materials and
Methods") were designed to amplify the six known mouse trp
genes (26, 27). Products from all six trp genes were
detected in TC3-neo cells and mouse brain. In MIN-6 cells,
trp-1, trp-2, trp-4, and trp-6 were expressed, whereas trp-3 and
trp-5 were not reproducibly observed. In mouse islets all of
the trp gene products were evident except trp-5.
RT-PCR experiments with mock cDNA synthesis in the absence of
reverse transcriptase were done in parallel, and no bands were
observed, excluding amplification of genomic DNA (data not shown). All
six trp PCR products from the brain and TC3
amplifications were cloned and sequenced, revealing identity to those
reported previously (26, 27). We then characterized the expression of
trp genes using Northern blots comparing total RNA prepared from mouse brain and TC3 cells (Fig.
7). This showed that, despite amplification of most of the trp genes by RT-PCR, only
mtrp-4 message was readily detectable in TC3 cells, while
five of six trp transcripts (the exception being
trp-2, a putative pseudogene; Ref. 24) were visualized in
brain RNA. Prolonged exposures (>1 week) of several blots revealed
very faint bands in TC3 RNA corresponding to trp-1 and
trp-3 (data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 7.
Analysis of mammalian trp
expression in insulin-secreting cells. Northern blots comparing
trp expression in RNA isolated from mouse brain (lane
1) and TC3-neo cells (lane 2). Panels
1-6 indicate the trp gene probe employed
(i.e. trp1-6). Note that the trp-2 probe
(panel 2, arrowhead) gave a faint band at about
7.5 kilobase pairs in mouse brain. The location of the trp-6
transcript is indicated (panel 6, arrowhead).
trp-4 expression was nearly equivalent in the mouse brain
and TC3-neo RNA (panel 4). Lane 3 in
panel 4 contains purified brain ribosomal RNA as a control.
Each blot shown is representative of at least four experiments.
|
|
 |
DISCUSSION |
We have employed a -cell model, the TC3-neo cell, to study
the underlying mechanisms that regulate glucose-induced oscillations of
[Ca2+]i and insulin secretion. Previous studies
in insulinoma cells and islets have demonstrated a close coupling
between glucose-stimulated oscillations in membrane potential and the
consequent oscillations in [Ca2+]i and insulin
secretion (14, 15, 20). However, precise identification of the
signaling events underlying oscillations has remained elusive. In this
study, we have demonstrated the importance of a nonselective cation
current activated following depletion of intracellular Ca2+
stores in the regulation of glucose-dependent oscillations
of [Ca2+]i and show that activation of
ICRAN potentiates insulin secretion. Our
findings suggest that this ionic conductance generated by the discharge
and refilling of intracellular calcium stores plays a critical role in
regulating glucose-induced oscillatory signaling in -cells.
Similar to the responses elicited in mouse primary -cell clusters
and islets, glucose stimulation of insulin-secreting TC3-neo cells
results in synchronous oscillations in membrane potential and
[Ca2+]i (20). However, activation of the
oscillations required the additional presence of TEA. In this respect,
the TC3 cells more closely resemble rat islets, which also do not
respond to glucose with large amplitude oscillations in
[Ca2+]i, but can be induced to do so by TEA (20).
This probably reflects subtle differences between the expression levels
of K+ channels between -cells of different species.
Recently, we determined that the glucose-dependent effects
of TEA on TC3-neo cells stemmed from inhibition of delayed rectifier
K+ channels (KDR) (20). TC3-neo cells have a
similar complement of KDR subtypes to normal rodent
-cells, and express Shab (Kv2.1)- and Shaw
(Kv3.2)-related transcripts (18, 20). Under conditions where
IKDR is blocked, TC3-neo cells display
glucose-dependent oscillatory responses of the types seen
in intact mouse islets or -cell clusters. This suggests that the
TC3-neo cell line will prove useful as a relevant model to examine
the ion conductances underlying glucose-stimulated oscillatory behavior
in islets.
Several models have been advanced to explain islet bursting activity
induced by glucose. One of the earliest proposed that Ca2+
influx during the active phase caused a slow rise in
[Ca2+]i, which activated
IKCa that in turn repolarized the membrane
potential and inactivated ICa (37). Our data are
not consistent with this model, since oscillations were observed in the
presence of 10-20 mM TEA (20), conditions under which
IKCa should be completely suppressed by TEA
(Kd, 140 µM) (17). A more recent model
suggests that cyclic inhibition of IKATP, or a
direct coupling between cellular fuel metabolism and electrical activity in -cells acts as the -cell membrane potential
oscillator (15, 32). Our findings that in the presence of complete
block of IKATP with tolbutamide,
[Ca2+]i oscillations identical in nature to those
induced by glucose are produced would rule out a requirement for
oscillations in IKATP, and by inference
metabolism, being responsible. Although cyclic variations in KATP
activity or glucose metabolism were not a prerequisite for the
induction and maintenance of [Ca2+]i
oscillations, glucose was nonetheless an important activator of
oscillatory behavior. This permissive effect of glucose and tolbutamide
is most likely related to blockade of the repolarizing influence of
IKATP, the predominant ionic current in
pancreatic -cells. In support of this contention, direct overriding
of IKATP using depolarizing concentrations of
KCl was similarly able to substitute for both glucose or tolbutamide in
permitting the induction of [Ca2+]i oscillations.
As will be discussed further, the inhibition of
IKATP allows smaller conductance(s) to exert
significant effects on the membrane potential and, indirectly, on
[Ca2+]i.
In addition to stimulating the influx of Ca2+ as a result
of depolarization-induced opening of VDCCs, it has been recently
suggested that glucose mobilizes intracellular Ca2+ from
the ER (5-7). As a corollary of this triggered release, glucose has
been demonstrated by a number of groups to stimulate the sequestration
of Ca2+ in the ER (34, 38, 39). The state of filling of the
ER with Ca2+ in turn seems to regulate a plasma membrane
nonselective cation channel in pancreatic -cells, akin to the
"capacitative" Ca2+ entry system described in
non-excitable cells (40). This pathway permits the refilling of
depleted intracellular Ca2+ stores by activation of a
voltage-independent Ca2+ current called
ICRAC (Ca2+ release-activated
Ca2+ current), that directly supplies Ca2+ to
the depleted organelle (41). By contrast, in -cells
ICRAN enhances the entry of Ca2+
through ICa by causing a sustained membrane
depolarization (21). We have confirmed the presence of
ICRAN in TC3 cells using patch clamp
techniques, whose properties are indistinguishable from the current
previously described in primary mouse -cells (21). Thus, the current
is activated by exposure to MTX and the principal permeating ion seems
to be Na+; the reversal potential of around 10 mV
confirms the nonselective nature of the channel.
Since in other cell systems the mobilization of intracellular
Ca2+ stores is often oscillatory in nature (42), this
suggests that a conductance activated by the state of filling of
intracellular Ca2+ stores (e.g.
ICRAN) would similarly oscillate and could therefore underlie the membrane potential oscillations seen in islets and -cells exposed to glucose. It was therefore of great interest to
observe that pharmacological manipulation of
ICRAN resulted in alterations in
[Ca2+]i oscillations in TC3-neo cells that
were consistent with such a role for the channel. Thus, depletion of
intracellular Ca2+ stores with thapsigargin to induce
activation of ICRAN resulted in a conversion of
oscillatory alterations in [Ca2+]i to a sustained
rise. That this was due to continuous entry of Ca2+ through
ICa, activated as a consequence of
ICRAN-dependent membrane depolarization, was demonstrated by the ablative effects of the L-type
Ca2+ channel inhibitor
nitrendipine.3 Consistent
with its effects on glucose-stimulated alterations in
[Ca2+]i, thapsigargin potentiated the insulin
secretion response of TC3-neo cells elicited by glucose and TEA.
Direct activation of ICRAN following exposure to
MTX induced a similar, nitrendipine-sensitive sustained elevation in
[Ca2+]i. MTX also stimulated insulin secretion in
the presence of glucose alone, to the same extent as that produced by
the combined administration of glucose, TEA and thapsigargin.
Interestingly, in the absence of glucose, MTX was without effect on
insulin secretion,3 consistent with the proposal that the
MTX-activated current is of small magnitude and unable to override
IKATP, which would be activated under these
conditions. Suppression of current flow through
ICRAN had the opposite effect on the
glucose-stimulated [Ca2+]i oscillations in
TC3-neo cells. Thus, SKF 96365, a blocker of intracellular
Ca2+ store release-activated channels (35) completely
suppressed glucose-induced [Ca2+]i oscillations.
Although this compound has also been shown to block L-type calcium
channels at high concentrations, the demonstration that KCl-induced
depolarization raised [Ca2+]i in the presence of
SKF 96365 suggests that voltage-dependent calcium channels
were not inhibited. Furthermore, reduction of extracellular
Na+, the principal permeating ion through
ICRAN, similarly ablated the glucose stimulated
oscillations.
We initially characterized the putative molecular identity of
ICRAN using RT-PCR with Southern blot analysis,
and identified trp genes (trp1-6) expressed
differentially in two mouse insulinoma cells and islets of Langerhans.
These findings are in partial agreement with recent studies in which
the expression of mouse trp-1 was reported in MIN6 cells
(43). However, upon Northern blot analysis, trp-4 was the
only detectable trp transcript expressed in TC3
insulinoma cells, whereas five of the six genes were readily identified
in mouse brain (Fig. 7).
Drosophila trp and trp-like (trpl)
genes encode Ca2+ store-operated Ca2+ channels
and inositol 1,4,5-trisphosphate-activated nonselective cation
channels, respectively (22, 23). Recent evidence has suggested that
mammalian trp family channels may have several activation
mechanisms, with functional channels encoded by multiple subunits (44).
Mammalian trp genes are unlikely to direct the expression of
ICRAC, as none of the expressed trp
genes to date are able to reproduce the Ca2+ selectivity or
single channel conductance (0.03 picosiemens) of the native channel
(44). For example, htrp-1, also termed hTrpC1, encodes a
nonselective channel activated by depletion of Ca2+ stores
with a single channel conductance of 16 picosiemens (45). Both TrpC1
and TrpC3 can increase calcium entry following depletion of
intracellular stores (27). When transfected into murine
L(tk ) cells, a mixture of plasmids containing antisense
cDNAs for six mouse trp genes eliminated the
thapsigargin-induced increase in [Ca2+]i (27),
and a similar transfection with a 1.2-kilobase pair antisense fragment
to mtrp4 alone also eliminated receptor-stimulated calcium
entry (46). mtrp6 was likewise found to increase
Ca2+ entry when stimulated by activation of a cotransfected
muscarinic receptor, an effect that was blocked by SKF 96365, an agent
we employed here to also block store-operated currents (47). The similarity of ICRAN to trp family
channels is further supported by the finding of a single channel
conductance of 25 picosiemens for the MTX-sensitive nonselective cation
channel activated by ER Ca2+ store depletion in
fibroblasts, within the range reported for htrp-1 (48). Our
findings thus support the likelihood that trp-related genes
encode not only the current we have termed
ICRAN, but also the
Na+-dependent inward currents that cause rises
in [Ca2+]i in -cells following
Ca2+ store depletion with carbachol, acetylcholine,
pituitary adenylate cyclase activating polypeptide, and glucagon-like
peptide-1 (49-52).
Fig. 8 depicts a model in which
ICRAN regulates glucose-stimulated
oscillations of membrane potential and [Ca2+]i.
This model provides an explanation for the oscillatory behavior of
TC3-neo cells in the presence of glucose, and may also be applicable
to islet responses following nutrient stimulation. An experimental
model centered around ICRAN modulation has also recently been advocated to explain the effects of carbachol on [Ca2+]i and membrane potential (49). In
conclusion, our data suggest that ICRAN
modulation plays a critical role in controlling nutrient-dependent electrical bursting behavior in islets,
and also demonstrates that alterations in ICRAN
activity modulate insulin secretion. Since defective ER
Ca2+ sequestration has been demonstrated in several animal
models of non-insulin-dependent diabetes mellitus (53, 54),
it is possible that alterations in ICRAN
regulation may play a role in aberrant insulin secretion responses in
some forms of non-insulin-dependent diabetes mellitus.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Proposed model for the role of an ER
Ca2+ store depletion-activated nonselective cation channel
in regulating [Ca2+]i oscillations in membrane
potential and [Ca2+]i in
insulin-secreting cells. In the upper panel is shown
experimentally observed alterations in [Ca2+]i in
a single TC3-neo cell following a step increase in glucose from 0 to
1 mM (filled bar), and the subsequent effect of
exposure to 20 mM TEA (open bar). The vertical
calibration marks represent the
F340/F380 fluorescence
ratio for the Fura-2 [Ca2+]i estimations. The
lower panels represent a schematic -cell, comprising
(from left to right) an extracellular space, the plasma membrane, an
intracellular space, the endoplasmic reticulum membrane, and an
intracellular Ca2+ storage compartment. Shown are the
predicted changes in plasma membrane ion channel and ER
Ca2+ pump activity occurring during the corresponding
segments I-IV. The size of the blue shaded area in the
storage compartment represents the content of the store. The
solid circles in the plasma membrane and ER represent
Ca2+ the glucose transporter (GLUT2) and the
thapsigargin-sensitive ER Ca2+ ATPase, respectively. The
yellow boxes represent membrane ion channels. Going
counterclockwise from GLUT2, they are: the ATP-sensitive K+
channel (KATP), the delayed rectifier K+ channel (Kv), the
voltage-dependent Ca2+ channel (VDCC), and the
calcium store release-activated nonselective cation channel (CRNSC).
Their respective permeating cations, K+, Ca2+,
and Na+ are shown in the vicinity of the channel entrance
vestibule. The large arrows originating in the intracellular
Ca2+ storage compartment represent Ca2+ release
and the putative retrograde signal emanating from the ER and regulating
CRNSC (solid and unfilled, respectively). The
influx of Ca2+ through VDCC is determined by the balance
between the magnitude (represented by the size of arrow) of
outward repolarizing current through KATP and Kv, versus the
inward depolarizing current through CRNSC. Thus, Ca2+
influx occurs only when the current flow through CRNSC exceeds that
through KATP and Kv. In the absence of glucose, outward K+
current flow through KATP more than offsets the inward current flowing
through CRNSC open as a consequence of the partially depleted
intracellular Ca2+ stores (panel I). Following
exposure to stimulatory concentrations of glucose, cellular ATP begins
to rise. This increase initially provides energy substrate to activate
Ca2+ pumps located in the ER, thereby loading intracellular
Ca2+ stores. As ATP continues to rise, the current flow
through KATP diminishes, allowing some membrane depolarization, driven
by Na+ entry through CRNSC (panel II), resulting
in a partial activation of VDCC and a modest increase in
[Ca2+]i. This depolarization, however, also
activates the voltage-dependent Kv channels, and the
outward flow of K+ acts to prevent further membrane
depolarization. Block of Kv channels (with TEA) (panel III)
reduces this repolarizing influence. The resultant unfettered
depolarization, either directly or indirectly through inositol
1,4,5-trisphosphate (2), eventually triggers release of intracellular
Ca2+ stores. The now empty intracellular Ca2+
store induces full activation of CRNSC the consequence of which is an
accelerated rate of depolarization, which recruits more VDCCs leading
to an augmented influx of Ca2+. Ca2+ influx
continues until the ER Ca2+ stores are filled, at which
time the store depletion signal switches off and CRNSCs deactivate. Due
to residual outflow of K+ through partially inhibited KATP
and the closing of CRNSC the membrane hyperpolarizes, thereby
deactivating VDCC (panel IV). The assumption as to the
hyperpolarizing action of residual KATP is based on the experimental
observation that increasing concentrations of tolbutamide or
combination of tolbutamide and glucose cause conversion of
[Ca2+]i oscillations into a sustained rise (see
Footnote 3). A subsequent release of Ca2+ initiates a cycle
of ER Ca2+ store release and refilling, which results in
cyclical activation and inactivation of CRNSC and thereby indirectly
regulates the degree of calcium influx through VDCC (panels III
and IV).
|
|
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. E-mail:
id22327{at}glaxowellcome.com.
1
The abbreviations used are:
[Ca2+]i, intracellular free Ca2+
concentration; CRNSC, calcium release-activated nonselective cation
channel; ER, endoplasmic reticulum; ICa, calcium
current; ICRAC, Ca2+
release-activated Ca2+ current;
ICRAN, calcium release-activated nonselective
cation current; IKATP, ATP-sensitive
K+ current; IKCa, calcium-activated
K+ current; IKDR, delayed rectifier
K+ current; KATP, ATP-sensitive K+ channel; Kv,
delayed rectifier K+ channel; mtrp, murine
trp; MTX, maitotoxin; PCR, polymerase chain reaction; RT,
reverse transcriptase; TEA, tetraethylammonium; trp;
transient receptor potential gene; VDCC, voltage-dependent Ca2+ channel.
2
F. Qian and L. H. Philipson, manuscript in
preparation.
3
M. W. Roe, A. A. Mittal, L. H. Philipson, and I. D. Dukes, unpublished observations.
 |
REFERENCES |
-
Prentki, M.,
and Matschinsky, F. M.
(1987)
Physiol. Rev.
67,
1185-1248[Free Full Text]
-
Keahy, H. H. H.,
Rajan, A. S.,
Boyd, A. E., III,
and Kunze, D. L.
(1989)
Diabetes
38,
188-193[Abstract]
-
Rorsman, P.,
Ämmälä, P.,
Berggren, P.,
Bokvist, K.,
and Larsson, O.
(1992)
EMBO J.
11,
2877-2884[Medline]
[Order article via Infotrieve]
-
Dukes, I. D.,
and Cleemann, L.
(1993)
Am. J. Physiol.
264,
E348-E353[Abstract/Free Full Text]
-
Roe, M. W.,
Lancaster, M. E.,
Mertz, R. J.,
Worley, J. F., III,
and Dukes, I. D.
(1993)
J. Biol. Chem.
268,
9953-9956[Abstract/Free Full Text]
-
Rojas, E.,
Carroll, P. B.,
Ricordi, C.,
Boschero, A. C.,
Stojilkovic, S. S.,
and Atwater, I.
(1994)
Endocrinology
134,
1771-1781[Abstract/Free Full Text]
-
Gromada, J,
Frøkjær-Jensen, J,
and Dissing, S.
(1996)
Biochem. J.
314,
339-345
-
Cook, D. L.,
and Hales, C. N.
(1984)
Nature
312,
446-448[CrossRef][Medline]
[Order article via Infotrieve]
-
Dukes, I. D.,
McIntyre, M. S.,
Mertz, R. J.,
Philipson, L. H.,
Roe, M. W.,
Spencer, B.,
and Worley, J. F., III
(1994)
J. Biol. Chem.
269,
10979-10982[Abstract/Free Full Text]
-
Henquin, J. C.,
and Meissner, H. P.
(1984)
Experientia (Basel)
40,
1043-1052
-
Valdeolmillos, M.,
Santos, R. M.,
Contreras, D.,
Soria, B.,
and Rosario, L. M.
(1989)
FEBS Lett.
259,
19-23[CrossRef][Medline]
[Order article via Infotrieve]
-
Worley, J. F., III,
McIntyre, M. S.,
Spencer, B.,
Mertz, R. J.,
Roe, M. W.,
and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
14359-14362[Abstract/Free Full Text]
-
Gilon, P.,
and Henquin, J. C.
(1992)
J. Biol. Chem.
267,
20713-20720[Abstract/Free Full Text]
-
Gilon, P.,
Shepherd, R. M.,
and Henquin, J. C.
(1993)
J. Biol. Chem.
268,
22265-22268[Abstract/Free Full Text]
-
Satin, L. S.,
and Smolen, P. D.
(1994)
Endocrine
2,
677-687
-
Keizer, J.
(1995)
Biophys. J.
68,
2216-2217[Medline]
[Order article via Infotrieve]
-
Ashcroft, F. M.,
and Rorsman, P.
(1989)
Prog. Biophys. Mol. Biol.
54,
87-143[CrossRef][Medline]
[Order article via Infotrieve]
-
Dukes, I. D.,
and Philipson, L. H.
(1996)
Diabetes
45,
845-853[Abstract]
-
Philipson, L. H.,
Rosenberg, M. P.,
Kuznetsov, A.,
Lancaster, M. E.,
Worley, J. F., III,
Roe, M. W.,
and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
27787-27790[Abstract/Free Full Text]
-
Roe, M. W.,
Worley, J. F., III,
Mittal, A. A.,
Kuznetsov, A.,
DasGupta, S.,
Mertz, R. J.,
Witherspoon, S. M., III,
Blair, N.,
Lancaster, M. E.,
McIntyre, M. S.,
Shehee, W. R.,
Dukes, I. D.,
and Philipson, L. H.
(1996)
J. Biol. Chem.
271,
32241-42246[Abstract/Free Full Text]
-
Worley, J. F., III,
McIntyre, M. S.,
Spencer, B.,
and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
32055-32058[Abstract/Free Full Text]
-
Hardie, R. C.,
and Minke, B.
(1992)
Neuron
8,
643-651[CrossRef][Medline]
[Order article via Infotrieve]
-
Phillips, A. M.,
Bull, A.,
and Kelly, L. E.
(1992)
Neuron
8,
631-642[CrossRef][Medline]
[Order article via Infotrieve]
-
Wes, P. D.,
Chevesich, J.,
Jeromin, A.,
Rosenberg, C.,
Stetten, G.,
and Montell, C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
9652-9656[Abstract/Free Full Text]
-
Bennett, D. L.,
Petersen, C. C. H.,
and Cheek, T. R.
(1995)
Curr. Biol.
5,
1225-1228[CrossRef][Medline]
[Order article via Infotrieve]
-
Petersen, C. C. H.,
Berridge, M. J.,
Borgese, F.,
and Bennett, D. L.
(1995)
Biochem. J.
311,
41-44
-
Zhu, X.,
Jiang, M.,
Peyton, M.,
Boulay, G.,
Hurst, R.,
Stefani, E.,
and Birnbaumer, L.
(1996)
Cell
85,
661-671[CrossRef][Medline]
[Order article via Infotrieve]
-
Philipp, S.,
Cavalie, A.,
Frichel, M.,
Wissenbach, U.,
Zimmer, S.,
Trust, C.,
Marquart, A.,
Murakami, M.,
and Flockerzi, V.
(1996)
EMBO J.
18,
6166-6171
-
Efrat, S.,
Linde, S.,
Kofod, H.,
Spector, D.,
Delannoy, M.,
Grant, S.,
Hanahan, D.,
and Baekkeskov, S.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
9037-9041[Abstract/Free Full Text]
-
Hamaguchi, K.,
Gaskins, H. R.,
and Leiter, H. E.
(1991)
Diabetes
40,
842-849[Abstract]
-
Longo, E. A.,
Tornheim, K.,
Deeney, J. T.,
Varnum, B. A.,
Tillotson, D.,
Prentki, M.,
and Corkey, B. E.
(1991)
J. Biol. Chem.
266,
9314-9319[Abstract/Free Full Text]
-
Smolen, P.,
and Keizer, J.
(1992)
J. Membr. Biol.
127,
9-19[Medline]
[Order article via Infotrieve]
-
Jackson, T. R.,
Patterson, S. I.,
Thastrup, O.,
and Hanley, M. R.
(1988)
Biochem. J.
253,
81-86[Medline]
[Order article via Infotrieve]
-
Roe, M. W.,
Lancaster, M. E.,
Mertz, R. J.,
Worley, J. F., III,
and Dukes, I. D.
(1994)
Am. J. Physiol.
266,
E852-E862[Abstract/Free Full Text]
-
Rink, T. J.
(1990)
FEBS Lett.
268,
381-385[CrossRef][Medline]
[Order article via Infotrieve]
-
Musgrave, I. F.,
Seifert, R.,
and Schultz, G.
(1994)
Biochem. J.
301,
437-441
-
Atwater, I.,
Ribalet, B.,
and Rojas, E.
(1978)
J. Physiol.
278,
117-139[Abstract/Free Full Text]
-
Nadal, A.,
Valdeolmillos, M.,
and Soria, B.
(1994)
Am. J. Physiol.
267,
E769-E774[Abstract/Free Full Text]
-
Chow, R. H.,
Lund, P. E.,
Loser, S.,
Panten, U.,
and Gylfe, E.
(1995)
J. Physiol.
485,
607-617[Abstract/Free Full Text]
-
Putney, J. W., Jr.
(1986)
Cell Calcium
7,
1-12[CrossRef][Medline]
[Order article via Infotrieve]
-
Pozzan, T.,
Rizzuto, R.,
Volpe, P.,
and Meldolesi, J.
(1994)
Physiol. Rev.
74,
595-636[Free Full Text]
-
Berridge, M. J.
(1995)
Ann. N. Y. Acad. Sci.
766,
31-43[Medline]
[Order article via Infotrieve]
-
Sakura, H.,
and Ashcroft, F. M.
(1997)
Diabetologia
528,
528-532
-
Clapham, D. E.
(1996)
Neuron
16,
1069-1072[CrossRef][Medline]
[Order article via Infotrieve]
-
Zitt, C.,
Zobel, A.,
Obukjov, A. G.,
Harteneck, C.,
Kalkbrenner, F.,
Luckhoff, A.,
and Schultz, G.
(1996)
Neuron
16,
1189-1196[CrossRef][Medline]
[Order article via Infotrieve]
-
Birnbaumer, L.,
Zhu, X.,
Jiang, M.,
Boulay, G.,
Peyton, M.,
Vannier, B.,
Brown, D.,
Platano, D.,
Sadeghi, H.,
Stefani, E.,
and Birnbaumer, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
15195-15202[Abstract/Free Full Text]
-
Boulay, G.,
Zhu, X.,
Peyton, M.,
Jiang, M.,
Hurst, R.,
Stefani, E.,
and Birnbaumer, L.
(1997)
J. Biol. Chem.
272,
29672-29680[Abstract/Free Full Text]
-
Dukes, I. D.,
McIntyre, M. S.,
and Worley, J. F., III
(1995)
Biophys. J.
68,
A121[CrossRef] (abstr.)
-
Silva, A. M.,
Rosario, L. M.,
and Santos, R. M.
(1994)
J. Biol. Chem.
269,
17095-17103[Abstract/Free Full Text]
-
Bertram, R.,
Smolen, P.,
Sherman, A.,
Mears, D.,
Atwater, I.,
Martin, F.,
and Soria, B.
(1995)
Biophys. J.
68,
2322-2332
-
Leech, C. A.,
Holz, G. G.,
and Habener, J. F.
(1995)
Endocrinology
136,
1530-1536[Abstract]
-
Holz, G. G., IV,
Leech, C. A.,
and Habener, J. F.
(1995)
J. Biol. Chem.
270,
17749-17757[Abstract/Free Full Text]
-
Roe, M. W.,
Philipson, L. H.,
Frangakis, C. J.,
Kuznetsov, A.,
Mertz, R. J.,
Lancaster, M. E.,
Spencer, B.,
Worley, J. F., III,
and Dukes, I. D.
(1994)
J. Biol. Chem.
269,
18279-18282[Abstract/Free Full Text]
-
Veradi, A.,
Molnar, E.,
Ostenson, C. G.,
and Ashcroft, S. J.
(1996)
Biochem. J.
319,
521-552
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Jahanshahi, R. Wu, J. D. Carter, and C. S. Nunemaker
Evidence of Diminished Glucose Stimulation and Endoplasmic Reticulum Function in Nonoscillatory Pancreatic Islets
Endocrinology,
February 1, 2009;
150(2):
607 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hiriart and L. Aguilar-Bryan
Channel regulation of glucose sensing in the pancreatic {beta}-cell
Am J Physiol Endocrinol Metab,
December 1, 2008;
295(6):
E1298 - E1306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Koizumi and T. Yada
Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic {beta}-cells
J. Endocrinol.,
May 1, 2008;
197(2):
221 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bao, Y. Li, X. Lei, M. Wohltmann, W. Jin, A. Bohrer, C. F. Semenkovich, S. Ramanadham, I. Tabas, and J. Turk
Attenuated Free Cholesterol Loading-induced Apoptosis but Preserved Phospholipid Composition of Peritoneal Macrophages from Mice That Do Not Express Group VIA Phospholipase A2
J. Biol. Chem.,
September 14, 2007;
282(37):
27100 - 27114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kaznacheyeva, L. Glushankova, V. Bugaj, O. Zimina, A. Skopin, V. Alexeenko, L. Tsiokas, I. Bezprozvanny, and G. N. Mozhayeva
Suppression of TRPC3 Leads to Disappearance of Store-operated Channels and Formation of a New Type of Store-independent Channels in A431 Cells
J. Biol. Chem.,
August 10, 2007;
282(32):
23655 - 23662.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Jacobson, C. R. Weber, S. Bao, J. Turk, and L. H. Philipson
Modulation of the Pancreatic Islet beta-Cell-delayed Rectifier Potassium Channel Kv2.1 by the Polyunsaturated Fatty Acid Arachidonate
J. Biol. Chem.,
March 9, 2007;
282(10):
7442 - 7449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bao, H. Song, M. Wohltmann, S. Ramanadham, W. Jin, A. Bohrer, and J. Turk
Insulin Secretory Responses and Phospholipid Composition of Pancreatic Islets from Mice That Do Not Express Group VIA Phospholipase A2 and Effects of Metabolic Stress on Glucose Homeostasis
J. Biol. Chem.,
July 28, 2006;
281(30):
20958 - 20973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bao, A. Bohrer, S. Ramanadham, W. Jin, S. Zhang, and J. Turk
Effects of Stable Suppression of Group VIA Phospholipase A2 Expression on Phospholipid Content and Composition, Insulin Secretion, and Proliferation of INS-1 Insulinoma Cells
J. Biol. Chem.,
January 6, 2006;
281(1):
187 - 198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Tamarina, A. Kuznetsov, C. J. Rhodes, V. P. Bindokas, and L. H. Philipson
Inositol (1,4,5)-Trisphosphate Dynamics and Intracellular Calcium Oscillations in Pancreatic {beta}-Cells
Diabetes,
November 1, 2005;
54(11):
3073 - 3081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Fridlyand, L. Ma, and L. H. Philipson
Adenine nucleotide regulation in pancreatic {beta}-cells: modeling of ATP/ADP-Ca2+ interactions
Am J Physiol Endocrinol Metab,
November 1, 2005;
289(5):
E839 - E848.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. R. Landa Jr., M. Harbeck, K. Kaihara, O. Chepurny, K. Kitiphongspattana, O. Graf, V. O. Nikolaev, M. J. Lohse, G. G. Holz, and M. W. Roe
Interplay of Ca2+ and cAMP Signaling in the Insulin-secreting MIN6 {beta}-Cell Line
J. Biol. Chem.,
September 2, 2005;
280(35):
31294 - 31302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Cruz-Cruz, A. Salgado, C. Sanchez-Soto, L. Vaca, and M. Hiriart
Thapsigargin-sensitive cationic current leads to membrane depolarization, calcium entry, and insulin secretion in rat pancreatic {beta}-cells
Am J Physiol Endocrinol Metab,
September 1, 2005;
289(3):
E439 - E445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kuznetsov, V. P. Bindokas, J. D. Marks, and L. H. Philipson
FRET-based voltage probes for confocal imaging: membrane potential oscillations throughout pancreatic islets
Am J Physiol Cell Physiol,
July 1, 2005;
289(1):
C224 - C229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, S. Ramanadham, Z. A. Ma, S. Bao, D. J. Mancuso, R. W. Gross, and J. Turk
Group VIA Phospholipase A2 Forms a Signaling Complex with the Calcium/Calmodulin-dependent Protein Kinase II{beta} Expressed in Pancreatic Islet {beta}-Cells
J. Biol. Chem.,
February 25, 2005;
280(8):
6840 - 6849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kajioka, S. Nakayama, H. Asano, and A. F. Brading
Involvement of ryanodine receptors in muscarinic receptor-mediated membrane current oscillation in urinary bladder smooth muscle
Am J Physiol Cell Physiol,
January 1, 2005;
288(1):
C100 - C108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bao, D. J. Miller, Z. Ma, M. Wohltmann, G. Eng, S. Ramanadham, K. Moley, and J. Turk
Male Mice That Do Not Express Group VIA Phospholipase A2 Produce Spermatozoa with Impaired Motility and Have Greatly Reduced Fertility
J. Biol. Chem.,
September 10, 2004;
279(37):
38194 - 38200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Liu, N. Hilliard, and G. H. Hockerman
Cav1.3 Is Preferentially Coupled to Glucose-Induced [Ca2+]i Oscillations in the Pancreatic {beta} Cell Line INS-1
Mol. Pharmacol.,
May 1, 2004;
65(5):
1269 - 1277.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. E. Fridlyand, N. Tamarina, and L. H. Philipson
Modeling of Ca2+ flux in pancreatic {beta}-cells: role of the plasma membrane and intracellular stores
Am J Physiol Endocrinol Metab,
July 1, 2003;
285(1):
E138 - E154.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yaekura, R. Julyan, B. L. Wicksteed, L. B. Hays, C. Alarcon, S. Sommers, V. Poitout, D. G. Baskin, Y. Wang, L. H. Philipson, et al.
Insulin Secretory Deficiency and Glucose Intolerance in Rab3A Null Mice
J. Biol. Chem.,
March 7, 2003;
278(11):
9715 - 9721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Calabrese, M. Zhang, V. Serre-Beinier, D. Caton, C. Mas, L. S. Satin, and P. Meda
Connexin 36 Controls Synchronization of Ca2+ Oscillations and Insulin Secretion in MIN6 Cells
Diabetes,
February 1, 2003;
52(2):
417 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.B. Goforth, R. Bertram, F.A. Khan, M. Zhang, A. Sherman, and L.S. Satin
Calcium-activated K+ Channels of Mouse {beta}-cells are Controlled by Both Store and Cytoplasmic Ca2+: Experimental and Theoretical Studies
J. Gen. Physiol.,
August 26, 2002;
120(3):
307 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Qian, P. Huang, L. Ma, A. Kuznetsov, N. Tamarina, and L. H. Philipson
TRP Genes: Candidates for Nonselective Cation Channels and Store-Operated Channels in Insulin-Secreting Cells
Diabetes,
February 1, 2002;
51(90001):
S183 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lane, G. Hao, and S. S. Gross
S-Nitrosylation Is Emerging as a Specific and Fundamental Posttranslational Protein Modification: Head-to-Head Comparison with O-Phosphorylation
Sci. Signal.,
June 12, 2001;
2001(86):
re1 - re1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Grimberg, R.J. Ferry Jr., A. Kelly, S. Koo-McCoy, K. Polonsky, B. Glaser, M.A. Permutt, L. Aguilar-Bryan, D. Stafford, P.S. Thornton, et al.
Dysregulation of Insulin Secretion in Children With Congenital Hyperinsulinism due to Sulfonylurea Receptor Mutations
Diabetes,
February 1, 2001;
50(2):
322 - 328.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
X. Wu, G. Babnigg, and M. L. Villereal
Functional significance of human trp1 and trp3 in store-operated Ca2+ entry in HEK-293 cells
Am J Physiol Cell Physiol,
March 1, 2000;
278(3):
C526 - C536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M Shepherd, K. E Cosgrove, R. E O'Brien, P. D Barnes, C. Ämmälä, and M. J Dunne
Hyperinsulinism of infancy: towards an understanding of unregulated insulin release
Arch. Dis. Child. Fetal Neonatal Ed.,
March 1, 2000;
82(2):
87F - 97.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Gromada, M. Hoy, E. Renstrom, K. Bokvist, L. Eliasson, S. Gopel, and P. Rorsman
CaM kinase II-dependent mobilization of secretory granules underlies acetylcholine-induced stimulation of exocytosis in mouse pancreatic B-cells
J. Physiol.,
August 1, 1999;
518(3):
745 - 759.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Aguilar-Bryan and J. Bryan
Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels
Endocr. Rev.,
April 1, 1999;
20(2):
101 - 135.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|